Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (134) Sarcoma
...CenterWatch: Clinical Trials in Category (134) Sarcoma Sarcoma State • Arkansas • California • Florida • Georgia • Idaho • Maryland • Massachusetts • Michigan • Minnesota • Nebraska • New Jersey • New York ...
View Page

2.  CenterWatch: New Medical Therapies in Disease Category (134), Sarcoma
...CenterWatch: New Medical Therapies in Disease Category (134), Sarcoma Sarcoma Patient Medical Areas • Oncology January 28, 2008 Threshold released results from a phase II trial ...
View Page

3.  Study Posting (4519) Trial #131688, Sarcoma, Manchester, United Kingdom
...Study Posting (4519) Trial #131688, Sarcoma, Manchester, United Kingdom Trial Information A Study of R1507 in Patients With Recurrent or Refractory Sarcoma. Status: Recruiting Protocol Number: NO21157 Sponsor: Hoffmann-La Roche; SARC Company Division: Pharmaceutical Official Scientific ...
View Page

4.  Study Posting (4519) Trial #131640, Sarcoma, London, United Kingdom
...Study Posting (4519) Trial #131640, Sarcoma, London, United Kingdom Trial Information A Study of R1507 in Patients With Recurrent or Refractory Sarcoma. Status: Recruiting Protocol Number: NO21157 Sponsor: Hoffmann-La Roche; SARC Company Division: Pharmaceutical Official Scientific ...
View Page

5.  Study Posting (4519) Trial #131828, Sarcoma, Birmingham, United Kingdom
...Study Posting (4519) Trial #131828, Sarcoma, Birmingham, United Kingdom Trial Information A Study of R1507 in Patients With Recurrent or Refractory Sarcoma. Status: Recruiting Protocol Number: NO21157 Sponsor: Hoffmann-La Roche; SARC Company Division: Pharmaceutical Official Scientific ...
View Page

6.  Study Posting (4519) Trial #131805, Sarcoma, Stockholm, Sweden
...Study Posting (4519) Trial #131805, Sarcoma, Stockholm, Sweden Trial Information A Study of R1507 in Patients With Recurrent or Refractory Sarcoma. Status: Recruiting Protocol Number: NO21157 Sponsor: Hoffmann-La Roche; SARC Company Division: Pharmaceutical Official Scientific ...
View Page

7.  Study Posting (4519) Trial #131876, Sarcoma, Lund, Sweden
...Study Posting (4519) Trial #131876, Sarcoma, Lund, Sweden Trial Information A Study of R1507 in Patients With Recurrent or Refractory Sarcoma. Status: Recruiting Protocol Number: NO21157 Sponsor: Hoffmann-La Roche; SARC Company Division: Pharmaceutical Official Scientific ...
View Page

8.  Study Posting (4519) Trial #131646, Sarcoma, Madrid, Spain
...Study Posting (4519) Trial #131646, Sarcoma, Madrid, Spain Trial Information A Study of R1507 in Patients With Recurrent or Refractory Sarcoma. Status: Recruiting Protocol Number: NO21157 Sponsor: Hoffmann-La Roche; SARC Company Division: Pharmaceutical Official Scientific ...
View Page

9.  Study Posting (4519) Trial #131644, Sarcoma, Barcelona, Spain
...Study Posting (4519) Trial #131644, Sarcoma, Barcelona, Spain Trial Information A Study of R1507 in Patients With Recurrent or Refractory Sarcoma. Status: Recruiting Protocol Number: NO21157 Sponsor: Hoffmann-La Roche; SARC Company Division: Pharmaceutical Official Scientific ...
View Page

10.  Study Posting (4519) Trial #131643, Sarcoma, Oslo, Norway
...Study Posting (4519) Trial #131643, Sarcoma, Oslo, Norway Trial Information A Study of R1507 in Patients With Recurrent or Refractory Sarcoma. Status: Recruiting Protocol Number: NO21157 Sponsor: Hoffmann-La Roche; SARC Company Division: Pharmaceutical Official Scientific ...
View Page

11.  Study Posting (4519) Trial #131696, Sarcoma, Rotterdam, Netherlands
...Study Posting (4519) Trial #131696, Sarcoma, Rotterdam, Netherlands Trial Information A Study of R1507 in Patients With Recurrent or Refractory Sarcoma. Status: Recruiting Protocol Number: NO21157 Sponsor: Hoffmann-La Roche; SARC Company Division: Pharmaceutical Official Scientific ...
View Page

12.  Study Posting (4519) Trial #131986, Sarcoma, Milano, Italy
...Study Posting (4519) Trial #131986, Sarcoma, Milano, Italy Trial Information A Study of R1507 in Patients With Recurrent or Refractory Sarcoma. Status: Recruiting Protocol Number: NO21157 Sponsor: Hoffmann-La Roche; SARC Company Division: Pharmaceutical Official Scientific ...
View Page

13.  Study Posting (4519) Trial #131797, Sarcoma, Bologna, Italy
...Study Posting (4519) Trial #131797, Sarcoma, Bologna, Italy Trial Information A Study of R1507 in Patients With Recurrent or Refractory Sarcoma. Status: Recruiting Protocol Number: NO21157 Sponsor: Hoffmann-La Roche; SARC Company Division: Pharmaceutical Official Scientific ...
View Page

14.  Study Posting (4519) Trial #132028, Sarcoma, Tübingen, Germany
...Study Posting (4519) Trial #132028, Sarcoma, Tübingen, Germany Trial Information A Study of R1507 in Patients With Recurrent or Refractory Sarcoma. Status: Recruiting Protocol Number: NO21157 Sponsor: Hoffmann-La Roche; SARC Company Division: Pharmaceutical Official Scientific ...
View Page

15.  Study Posting (4519) Trial #147944, Sarcoma, Münster, Germany
...Study Posting (4519) Trial #147944, Sarcoma, Münster, Germany Trial Information A Study of R1507 in Patients With Recurrent or Refractory Sarcoma. Status: Recruiting Protocol Number: NO21157 Sponsor: Hoffmann-La Roche; SARC Company Division: Pharmaceutical Official Scientific ...
View Page

16.  Study Posting (4519) Trial #131685, Sarcoma, Mannheim, Germany
...Study Posting (4519) Trial #131685, Sarcoma, Mannheim, Germany Trial Information A Study of R1507 in Patients With Recurrent or Refractory Sarcoma. Status: Recruiting Protocol Number: NO21157 Sponsor: Hoffmann-La Roche; SARC Company Division: Pharmaceutical Official Scientific ...
View Page

17.  Study Posting (4519) Trial #131890, Sarcoma, Bad Saarow, Germany
...Study Posting (4519) Trial #131890, Sarcoma, Bad Saarow, Germany Trial Information A Study of R1507 in Patients With Recurrent or Refractory Sarcoma. Status: Recruiting Protocol Number: NO21157 Sponsor: Hoffmann-La Roche; SARC Company Division: Pharmaceutical Official Scientific ...
View Page

18.  Study Posting (4519) Trial #131682, Sarcoma, Villejuif, France
...Study Posting (4519) Trial #131682, Sarcoma, Villejuif, France Trial Information A Study of R1507 in Patients With Recurrent or Refractory Sarcoma. Status: Recruiting Protocol Number: NO21157 Sponsor: Hoffmann-La Roche; SARC Company Division: Pharmaceutical Official Scientific ...
View Page

19.  Study Posting (4519) Trial #136399, Sarcoma, Paris, France
...Study Posting (4519) Trial #136399, Sarcoma, Paris, France Trial Information A Study of R1507 in Patients With Recurrent or Refractory Sarcoma. Status: Recruiting Protocol Number: NO21157 Sponsor: Hoffmann-La Roche; SARC Company Division: Pharmaceutical Official Scientific ...
View Page

20.  Study Posting (4519) Trial #131672, Sarcoma, Marseille, France
...Study Posting (4519) Trial #131672, Sarcoma, Marseille, France Trial Information A Study of R1507 in Patients With Recurrent or Refractory Sarcoma. Status: Recruiting Protocol Number: NO21157 Sponsor: Hoffmann-La Roche; SARC Company Division: Pharmaceutical Official Scientific ...
View Page